Birlotib 150 Tablet Substitute
RXZydus Cadila
₹3431
(₹93.78 per unit)
RX₹6400
(₹174.93 per unit)
RX₹7200
(₹196.8 per unit)
RX₹7200
(₹196.8 per unit)
RXBDR Pharmaceuticals Internationals Pvt Ltd
₹2340
(₹210.6 per unit)
RXMedicamen Biotech Ltd
₹6660
(₹222.0 per unit)
RXShilpa Medicare Ltd
₹2848.93
(₹233.61 per unit)
RXNatco Pharma Ltd
₹8768.5
(₹239.67 per unit)
RXKhandelwal Laboratories Pvt Ltd
₹8870.4
(₹242.46 per unit)
RXCipla Ltd
₹8908
(₹243.49 per unit)
RX₹12000
(₹328.0 per unit)
RXSamarth Life Sciences Pvt Ltd
₹7000
(₹574.0 per unit)
RXFresenius Kabi India Pvt Ltd
₹25000
(₹683.33 per unit)
RX₹9999
(₹819.92 per unit)
RXRPG Life Sciences Ltd
₹11159.8
(₹915.1 per unit)
Patients may explore substitutes in the following scenarios:
Before you switch from Birlotib 150 Tablet to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - ERLOTINIB-150MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Birlotib 150 Tablet is prescribed to the patients dealing with nonsmall cell lung cancer and pancreatic cancer. Cancer of this type tends to spread quickly in other parts of the body. Birlotib 150 Tablet travel through the bloodstream and effectively destroy cancerous cells of the lung, pancreas, and other body parts. Birlotib 150 Tablet contains Erlotinib is a 'tyrosine kinase inhibitor (TKI)' that stops the uncontrolled growth and spread of cancerous cells. It acts by blocking the abnormal protein's action that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed, it undergoes a usual process of maturity. Cancerous cells form new cells more quickly, so Birlotib 150 Tablet targets cancerous cells and block the action of Tyrosine kinases enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Birlotib 150 Tablet stops the production, spread, and growth of cancerous cells in the body.
The substitutes of Birlotib 150 Tablet contain the same active salt(s) - ERLOTINIB-150MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Birlotib 150 Tablet is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Birlotib 150 Tablet are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Birlotib 150 Tablet meet the same safety and efficacy standards as Birlotib 150 Tablet, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Birlotib 150 Tablet may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Birlotib 150 Tablet if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Birlotib 150 Tablet for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Birlotib 150 Tablet is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Birlotib 150 Tablet to its substitute. Always consult your doctor before switching.